Hudson Bay Capital Management’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-135,000
| Closed | -$1.27M | – | 778 |
|
|
2024
Q3 | $1.27M | Sell |
135,000
-115,000
| -46% | -$1.08M | 0.01% | 472 |
|
|
2024
Q2 | $2.01M | Buy |
250,000
+200,000
| +400% | +$1.6M | 0.01% | 423 |
|
|
2024
Q1 | $741K | Sell |
50,000
-225,000
| -82% | -$3.33M | ﹤0.01% | 474 |
|
|
2023
Q4 | $2.24M | Sell |
275,000
-155,200
| -36% | -$1.26M | 0.01% | 369 |
|
|
2023
Q3 | $1.96M | Buy |
430,200
+155,200
| +56% | +$706K | 0.02% | 415 |
|
|
2023
Q2 | $1.94M | Sell |
275,000
-218,553
| -44% | -$1.54M | 0.01% | 448 |
|
|
2023
Q1 | $3.02M | Buy |
493,553
+185,553
| +60% | +$1.13M | 0.02% | 400 |
|
|
2022
Q4 | $1.97M | Buy |
308,000
+208,000
| +208% | +$1.33M | 0.02% | 577 |
|
|
2022
Q3 | $958K | Hold |
100,000
| – | – | 0.01% | 821 |
|
|
2022
Q2 | $1.1M | Buy |
100,000
+75,000
| +300% | +$828K | 0.01% | 862 |
|
|
2022
Q1 | $416K | Buy |
+25,000
| New | +$416K | 0.01% | 861 |
|